Back to Top Skip to main content Skip to sub-navigation

San Antonio volunteers sought for Warp Speed vaccine trials

Image of Woman typing on laptop. Click to open a larger version of the image. Marcy Edwards, a Military Health System beneficiary, signs up for Operation Warp Speed, Nov. 2, 2020. Operation Warp Speed is a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (Photo courtesy of Jason Edwards.)

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | Vaccine Trials | Coronavirus and the COVID-19 Vaccine

Two San Antonio area Military Health System facilities are seeking volunteers from among the military beneficiary population to participate in a COVID-19 vaccine trial.

The trial is part of Operation Warp Speed, a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

The Brooke Army Medical Center aboard Joint Base San Antonio-Fort Sam Houston, and the Wilford Hall Ambulatory Surgical Center at Joint Base San Antonio-Lackland are among the five Department of Defense locations taking part in the Phase III trial to evaluate the vaccine under development by AstraZeneca.

The other sites are Naval Medical Center San Diego in California, Walter Reed National Military Medical Center in Bethesda, Maryland, and Fort Belvoir Community Hospital in Virginia.

"The San Antonio Military Health System is proud to answer the call to help serve the needs of our nation in these unprecedented times," said Air Force Maj. Gen. John DeGoes, SAMHS market director and 59th Medical Wing commander. "We are proud to be selected as a partner in the effort to accelerate development of COVID-19 vaccines."

Army Brig. Gen. Shan Bagby, BAMC commanding general added, “We are honored to be among those sites selected in support of this whole-of government effort to ensure safe, effective medical products are provided at a critical time to the American people. SAMHS has the existing research infrastructure and experience to make a significant contribution to this important effort.”

The AstraZeneca vaccine trial is one of many national trials being conducted through Operation Warp Speed, and the first to encompass the DOD. With more than 80 sites nationwide, the trial has an overall target enrollment of 30,000 participants. Military sites are looking to draw 3,000 of those volunteers, according to a DOD release.

DOD sites are open on a voluntary basis to Military Health System beneficiaries – active duty, retirees and family members 18 years of age and older.

Beneficiaries can sign up for consideration by reaching out to either site:

Wilford Hall Ambulatory Surgical Center (Site Code: WHASC)
Recruitment Phone Number: 253-341-6170
Email: covidwhasc@genevausa.org 

Brooke Army Medical Center (Site Code: BAMC)
Recruitment Phone Number: 253-924-9458
Email: covidbamc@genevausa.org 

Alternatively, volunteers can also visit www.CoronavirusPreventionNetwork.org, click on “Volunteer Now” and complete the survey. When requested, volunteers should enter the appropriate site code, depending on their preference and geographic location.

Once the survey is completed, local study site coordinators will screen volunteers and contact those participants in their area who may be a good match for the study. Volunteers should consult with the study coordinator if they are scheduled to move, change their duty station or deploy within 12 months of beginning participation.

According to the DOD release, the study is looking for people who are at an increased risk of SARS-CoV-2 infection, which may include:

  • Working in an essential job, such as healthcare professions, emergency response personnel, grocery workers, meat-packing plants, restaurant staff, public transit, etc.
  • Living in densely populated residential environments
  • Living or working in congregated living facilities, such as nursing homes
  • A member of a community that has been hardest hit by this pandemic, such as older people, individuals with underlying health conditions, and racial/ethnic groups such as African Americans, Latino, and Native American populations.

Volunteers selected will be enrolled into the study. Once the local sites are active, participants will be called in to receive two doses of the vaccine or placebo about a month apart.

Along with scheduled visits, participants will be asked to come in if they have symptoms throughout the year to be tested for COVID-19. Study participants will be followed for two years to determine the vaccine’s efficacy, while being compensated for their participation.

You also may be interested in...

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

About TRICARE | Coronavirus

DoD Guidance on the Use of Cloth Face Coverings

Publication
4/5/2020

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Recommended Content:

Coronavirus | Public Health

Policy on Accessions and Accessions Training during the COVID-19 Outbreak

Publication
4/3/2020

The Military Departments must seek ways to maximize accessions in a responsible manner to minimize a reduction in military end strength and the potential deterioration of mid-and long-term readiness and capacity.

Recommended Content:

Coronavirus

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

Publication
4/2/2020

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future of MTF Transition.

Recommended Content:

Coronavirus | Military Health System Transformation

Pharmacy Guidance for Market MTFs

Publication
3/31/2020

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Recommended Content:

Coronavirus | TRICARE Pharmacy Operations | About TRICARE

Tiered Telehealth Health Care Support for COVID-19

Publication
3/31/2020

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Recommended Content:

About TRICARE | Public Health | Coronavirus

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Recommended Content:

Coronavirus | About TRICARE

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Recommended Content:

Coronavirus | About TRICARE

MHS Minute Combatting COVID 19

Video
3/30/2020
MHS Minute Combatting COVID 19

Agencies across the federal government are partnering up to combat COVID-19. Find out how the Military Health System is doing its part to support the U.S. response to this pandemic, while ensuring our Service members remain ready.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

COVID-19 Life Support Training Extension

Publication
3/19/2020

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Recommended Content:

Coronavirus

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform

Congressional Testimony
3/11/2020

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus

MHS GENESIS Patient Portal Fact Sheet

Fact Sheet
7/30/2019

This fact sheet describes the MHS GENESIS Patient Portal.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | MHS GENESIS Toolkit

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

About TRICARE | Coronavirus

DoD Guidance on the Use of Cloth Face Coverings

Publication
4/5/2020

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Recommended Content:

Coronavirus | Public Health

Policy on Accessions and Accessions Training during the COVID-19 Outbreak

Publication
4/3/2020

The Military Departments must seek ways to maximize accessions in a responsible manner to minimize a reduction in military end strength and the potential deterioration of mid-and long-term readiness and capacity.

Recommended Content:

Coronavirus

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

Publication
4/2/2020

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future of MTF Transition.

Recommended Content:

Coronavirus | Military Health System Transformation

Pharmacy Guidance for Market MTFs

Publication
3/31/2020

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Recommended Content:

Coronavirus | TRICARE Pharmacy Operations | About TRICARE

Tiered Telehealth Health Care Support for COVID-19

Publication
3/31/2020

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Recommended Content:

About TRICARE | Public Health | Coronavirus

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Recommended Content:

Coronavirus | About TRICARE

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Recommended Content:

Coronavirus | About TRICARE

MHS Minute Combatting COVID 19

Video
3/30/2020
MHS Minute Combatting COVID 19

Agencies across the federal government are partnering up to combat COVID-19. Find out how the Military Health System is doing its part to support the U.S. response to this pandemic, while ensuring our Service members remain ready.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

COVID-19 Life Support Training Extension

Publication
3/19/2020

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Recommended Content:

Coronavirus

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform

Congressional Testimony
3/11/2020

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus

MHS GENESIS Patient Portal Fact Sheet

Fact Sheet
7/30/2019

This fact sheet describes the MHS GENESIS Patient Portal.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | MHS GENESIS Toolkit
<< < ... 36 37 38 39 40 > >> 
Showing results 586 - 597 Page 40 of 40

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.